As the Co-Founder and CEO of Eos Neuroscience, Ben Matteo is at the forefront of pioneering advancements in the biotech sector, specifically focusing on innovative treatments for vision restoration. With a profound commitment to changing lives, Eos Neuroscience is dedicated to developing a groundbreaking optogenetic...
As the Co-Founder and CEO of Eos Neuroscience, Ben Matteo is at the forefront of pioneering advancements in the biotech sector, specifically focusing on innovative treatments for vision restoration. With a profound commitment to changing lives, Eos Neuroscience is dedicated to developing a groundbreaking optogenetic therapy aimed at restoring functional vision in patients suffering from degenerative retinal diseases, such as retinitis pigmentosa and macular degeneration. Under Ben's leadership, the company has successfully demonstrated the safety and efficacy of its treatment in preclinical models, showcasing the potential to revolutionize the field of ophthalmology.
Ben's extensive background in both for-profit and non-profit sectors equips him with a unique perspective on business strategy and organizational development. His expertise in entrepreneurship and strategic partnerships has been instrumental in navigating the complexities of biotech innovation, ensuring that Eos Neuroscience not only thrives but also aligns with the broader mission of improving patient outcomes. His hands-on experience in product management and strategic sales allows him to effectively guide the company through various stages of growth, from initial concept to clinical application.
In addition to his work in neuroscience, Ben is passionate about clean technology, recognizing the importance of sustainable practices in the biotech industry. His multifaceted skill set, which includes business development and consulting, positions him as a thought leader in the intersection of biotechnology and renewable energy. As Eos Neuroscience continues to advance its pioneering research, Ben Matteo remains committed to fostering a culture of innovation and collaboration, driving the company toward its vision of restoring sight and enhancing quality of life for countless individuals.
